Andexanet for Major Hemorrhage in Patients on Factor Xa Inhibitors
NEJM Journal Watch（2019）
摘要
The anticoagulant activity of oral direct factor Xa (FXa) inhibitors and low-molecular-weight heparins such as enoxaparin can be reversed by andexanet,
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要